Australia

Getac Commissioned Survey Highlights Rugged Technology's Role In Transforming Industrial Operations

IRVINE, Calif., April 10, 2024 /PRNewswire/ -- Getac Technology Corporation , a leading producer of rugged technology, announced findings from the Getac-sponsored IDC InfoBrief titled, "Redefining Total Cost of Ownership: Rugged Technologies to Empower Industrial Operati...

2024-04-10 23:00 2911

AirCar developer signs groundbreaking manufacturing deal

KleinVision a.s., the Slovakia-based developer of the world's first certified flying car, the AirCar, has made a groundbreaking move towards realizing the dreams of individuals seeking to navigate through traffic congestion by taking to the skies in their cars NITRA, Slovakia, March 27, 2024 /PR...

2024-03-27 15:00 2006

White Cliff (ASX:WCN) unfurls historic high-grade uranium-copper from Northwest Territories

PERTH, Australia, March 26, 2024 /PRNewswire/ -- White Cliff Minerals dataset digitisation efforts have unearthed multiple high-grade uranium and copper targets in the northern half of its large-scale Radium Point exploration project inCanada's Northwest Territories. The older historical dataset...

2024-03-26 16:30 1513

Compute for Climate Fellowship Announces Inaugural Winners and Opens Applications for 2024

The program funds proof of concepts for new ideas leveraging advanced cloud computing, including generative AI and high-performance computing, to solve some of the biggest challenges in the fight against climate change LJUBLJANA, Slovenia, March 21, 2024 /PRNewswire/ -- The International Researc...

2024-03-21 20:00 2300

Enfinity Global completes a minority sale of its 400 MW operating portfolio in the United States to Kyushu Electric

MIAMI, March 19, 2024 /PRNewswire/ -- Enfinity Global Inc., a leader in renewable energy, today announced the successful completion of a minority sale in its 400 MW U.S. operating portfolio to Kyushu Electric Power Co. Inc. (Kyushu Electric), a leading Japanese utility. Kyushu Electric has now a ...

2024-03-19 14:30 2431

REC Wins Best Solar Panels and Best After-Sales Support in 2024 for the 2nd Year in a Row

MELBOURNE, Australia, March 15, 2024 /PRNewswire/ -- REC Group , an international pioneering solar energy company, is delighted to announce that it has been awarded "Best Sola...

2024-03-15 07:00 2764

Pulsenmore is expanding the application of its home ultrasound solution for pregnant women: a clinical trial with Michigan Medicine will focus on the remote assessment of the fetal biophysical profile

RAMAT GAN, Israel, March 13, 2024 /PRNewswire/ -- Pulsenmore (TASE:PULS), the world leader in self-scan ultrasound technology for at-home use and remote clinical diagnosis, announces its new clinical study collaboration with Michigan Medicine. The study will examine the ability to conduct a remot...

2024-03-14 06:00 3545

Additional COBRA results: SAR-bisPSMA detects lesions in the 2-millimetre range

Highlights * Clarity recently reported that in its diagnostic Phase 1/2 trial, COBRA, 64 Cu-SAR-bisPSMA was found to be safe and highly effective in detecting prostate cancer (PC) lesions in patients with biochemical recurrence (BCR). * In trial participants where standard of care (SOC) imagin...

2024-03-08 22:02 2710

PharmAust announces positive Phase 1 MEND Study Top-Line Results in MND / ALS

Highlights: * Monepantel displays a superior safety, tolerability to the leading FDA approved drug Relyvrio® * Preliminary efficacy data shows a 58% reduction in the rate of disease progression for Cohort 2 (High Dose) using the FDA primary efficacy endpoint, ALSFRS-R * Confirmation that m...

2024-02-28 20:47 1965

NIGO DESIGNS FIRST PENFOLDS GRANGE LIMITED-EDITION

An icon re-imagined. First-ever design takeover by cultural pioneer and Human Made Creative Director. ADELAIDE, Australia, Feb. 23, 2024 /PRNewswire/ -- Today Penfolds unveiled a new collaboration for Penfolds flagship wine, Grange. TheGrange by NIGO release celebrates the first-ever design take...

2024-02-23 15:07 2016

The Kingdom of Saudi Arabia unveils Zarqa Al Yamama - the inaugural Arabic Grand Opera

LONDON, Feb. 21, 2024 /PRNewswire/ -- Zarqa Al Yamama, the first Grand Opera produced by The Saudi Theater and Performing Arts Commission, one of the 11 sector specific commissions under the Ministry of Culture, was internationally unveiled at an exclusive event inLondon's historic Goldsmiths' Ha...

2024-02-21 21:40 2498

Glenmark, Jiangsu Alphamab Biopharmaceuticals and 3D Medicines announce the signing of a License Agreement for KN035 (Envafolimab) for Multiple Geographies around the World

* Glenmark will be responsible for further developing, registering, and commercializing Envafolimab inIndia, Asia Pacific, Middle East and Africa, Russia, CIS, and Latin America. * Jiangsu Alphamab and 3D Medicines will receive a low double digit Million US Dollar amount up to launch, additio...

2024-01-25 18:00 2306

Positive Xanamem® human PET study published in the Journal of Alzheimer's Disease demonstrating robust CNS[1] target enzyme occupancy

The study confirms that Xanamem is a brain-penetrant inhibitor of the tissue cortisol synthesis enzyme, 11β-HSD1, with high levels of target occupancy at doses as low as 5 mg SYDNEY, Jan. 24, 2024 /PRNewswire/ -- Actinogen Medical Limited (ASX: ACW) announces that its human Positron Emission Tom...

2024-01-24 21:30 2189

FDA CLEARANCE OF AMPLIA'S IND FOR PANCREATIC CANCER TRIAL IN US

HIGHLIGHTS * The US FDA has cleared Amplia's Investigational New Drug (IND) Application for a clinical trial of narmafotinib in theUSA * The proposed trial would explore the combination of narmafotinib and FOLFIRINOX in advanced pancreatic cancer patients in theUSA MELBOURNE, Australia ,Jan. ...

2024-01-18 10:31 1841

Style3D Research Shines the Show with additional Two Papers Accepted at SIGGRAPH ASIA 2023 on Cloth Simulation Innovations

SYDNEY, Jan. 10, 2024 /PRNewswire/ -- The electrifying stage of SIGGRAPH Asia 2023 witnessed Style3D Research's triumphant unveiling of two groundbreaking research papers through captivating oral presentations. This pinnacle gathering, renowned as a global hub for computer graphics, provided the ...

2024-01-11 02:00 2122

Seeing Machines unveils latest Guardian technology at CES 2024

-       Guardian is the company's world-leading Aftermarket Driver Monitoring System for commercial vehicles and is currently connected to 54,000 vehicles globally -       The new version includes Drowsiness Detection with refined microsleep detection and eye-gaze tracking to protect drivers fro...

2024-01-09 21:00 2422

Canadian Solar's e-STORAGE to Deliver 220 MWh DC of Battery Storage Solutions to Epic Energy's Mannum Project in South Australia

GUELPH, ON, Jan. 8, 2024 /PRNewswire/ -- Canadian Solar Inc . (the "Company" or "Canadian Solar") (NASDAQ: CSIQ) today announced thate-STORAGE , which is part of the Company's majority-owned subsidiary CSI Solar Co., Ltd. ("CSI Solar"), will...

2024-01-08 20:05 1861

Recurrent Energy Completes Sale of 100 MW/200 MWh Battery Energy Storage Project in South Australia to Epic Energy

GUELPH, ON, Jan. 8, 2024 /PRNewswire/ -- Canadian Solar Inc. (the "Company" or "Canadian Solar") (NASDAQ: CSIQ) today announced thatRecurrent Energy , a global developer and owner of solar and energy assets, completed the sale of its ...

2024-01-08 20:00 2006

GPN Vaccines Reports Positive Safety and Immunogenicity Data from its Phase 1 Trial of Gamma-PN

ADELAIDE, Australia, Jan. 3, 2024 /PRNewswire/ -- GPN Vaccines Ltd, a clinical-stage biotechnology company developing a Streptococcus pneumoniae vaccine to prevent life-threatening pneumonia, bacteraemia and meningitis, is pleased to announce positive safety and immunogenicity data from its Phase...

2024-01-04 04:30 2312

APL-2301, a compound developed by Asieris for the treatment of Acinetobacter baumannii infection, was approved for Phase I clinical trials in Australia

SHANGHAI, Dec. 24, 2023 /PRNewswire/ -- Asieris Pharmaceuticals (Stock Code: 688176.SH), a global biopharma company specializing in discovering, developing and commercializing innovative drugs for the treatment of genitourinary tumors and other related diseases, announced that its product, APL-23...

2023-12-24 17:53 3307
1 ... 9101112131415 ... 49

Week's Top Stories